Is a D-dimer of 0.98 µg/mL (FEU) in a 79‑year‑old male considered positive, and what diagnostic and treatment steps are recommended?

D-dimer Interpretation in a 79-Year-Old Male

A D-dimer of 0.98 µg/mL (FEU) in a 79-year-old male should be interpreted using an age-adjusted threshold of 0.79 µg/mL (79 × 0.01), making this result positive and requiring further diagnostic imaging if venous thromboembolism (VTE) is clinically suspected.

Age-Adjusted D-dimer Threshold

The 2019 ESC Guidelines explicitly recommend using age-adjusted D-dimer cut-offs (age × 10 µg/L, equivalent to age × 0.01 µg/mL) in patients over 50 years with low or intermediate clinical probability of pulmonary embolism 1. This approach has been prospectively validated and safely increases diagnostic specificity without compromising sensitivity.

For this 79-year-old patient:

• Age-adjusted threshold: 79 × 0.01 = 0.79 µg/mL
• Patient's D-dimer: 0.98 µg/mL
• Result: POSITIVE (exceeds age-adjusted threshold)

Clinical Probability Assessment Required

You must first determine the clinical probability of VTE before proceeding. The D-dimer result alone cannot guide management 1, 2.

Use a validated clinical probability tool:

• Wells Score for PE (simplified or 2-level version)
• Revised Geneva Score
• Wells Score for DVT (if lower extremity DVT suspected)

Diagnostic Algorithm Based on Clinical Probability:

If LOW or INTERMEDIATE (non-high) clinical probability:

• D-dimer 0.98 µg/mL is POSITIVE (above age-adjusted threshold of 0.79)
• Proceed to imaging: CT pulmonary angiography (CTPA) for PE or compression ultrasound (CUS) for DVT 1, 2
• The age-adjusted threshold has been validated with negative predictive values >99% in multiple prospective studies 3, 4

If HIGH clinical probability:

• Skip D-dimer entirely and proceed directly to imaging 2
• D-dimer testing is not recommended in high-probability patients as it does not safely exclude VTE

Evidence Supporting Age-Adjusted Thresholds

The ADJUST-PE study 4 prospectively validated age-adjusted D-dimer in 3,346 patients, demonstrating that among patients ≥75 years, using age-adjusted thresholds increased the proportion who could safely avoid imaging from 6.4% to 29.7%, with a failure rate of only 0.3%. A 2026 validation study in DVT 3 showed similar safety, with 0% false negatives in patients with D-dimer between 500 µg/L and their age-adjusted cutoff.

Clinical Context Matters

Important caveats for this 79-year-old patient:

• Comorbidities elevate D-dimer: Cancer, infection, recent surgery, heart failure, and inflammatory conditions can cause false positives even with age-adjusted thresholds
• Near-threshold zone: This patient's value (0.98) is relatively close to the threshold (0.79), placing him in a "near-threshold" zone where PE prevalence can reach 28.6% in patients ≥80 years 5
• Clinical reassessment crucial: If overall clinical suspicion remains high despite "low probability" scoring, proceed to imaging regardless

Recommended Next Steps

1. Calculate formal clinical probability score (Wells or Geneva)
2. If non-high probability: Order CTPA (if PE suspected) or proximal CUS (if DVT suspected)
3. If high probability: Proceed directly to imaging without relying on D-dimer
4. Do not use D-dimer as stand-alone rule-out in elderly patients 5

Common Pitfalls to Avoid

• Never use fixed 0.5 µg/mL threshold in patients >50 years - this leads to excessive false positives and unnecessary imaging 1, 4
• Never skip clinical probability assessment - D-dimer interpretation is meaningless without it 1, 2
• Don't order D-dimer in high-probability patients - it wastes time and resources 2
• Recognize assay-specific validation - age-adjusted thresholds are best validated with highly sensitive D-dimer assays like HemosIL D-Dimer HS 500 6, 7